Human cytochrome P450 aromatase (AROM, CYP19A1) use androgens as substrates with high specificity and catalyze them to estrogens [49], and its inhibitors, such as exemestane, were used to treat breast cancer for many years. This evidence concerns the gene CYP19A1 and breast cancer.